Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses.
Saved in:
| Title: | Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses. |
|---|---|
| Authors: | Larkin, Riley M.1,2 (AUTHOR), Lopez, Diana C.1,3 (AUTHOR), Robbins, Yvette L.4 (AUTHOR), Lassoued, Wiem5 (AUTHOR), Canubas, Kenneth5 (AUTHOR), Warner, Andrew6 (AUTHOR), Karim, Baktiar6 (AUTHOR), Vulikh, Ksenia6 (AUTHOR), Hodge, James W.5 (AUTHOR), Floudas, Charalampos S.5 (AUTHOR), Gulley, James L.5 (AUTHOR), Gallia, Gary L.3,7 (AUTHOR), Allen, Clint T.4 (AUTHOR), London Jr., Nyall R.1,3,7 (AUTHOR) nyall.london@nih.gov |
| Source: | Journal of Translational Medicine. 5/31/2024, Vol. 22 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14795876 |
|---|---|
| DOI: | 10.1186/s12967-024-05339-9 |